Artificial cornea nearing clinical trial stage

Article

An artificial cornea based on a commercially available polymer, may be ready for clinical testing early in 2008.

An artificial cornea based on a commercially available polymer, may be ready for clinical testing early in 2008.

The cornea, developed by members of the European Union-funded CORNEA project, is made from a polymer that does not absorb water and does not allow cells to grow on it. After shaping the polymer, the researchers selectively coated the implants by laying masks on them and then applying a protein to the edge of the cornea, which the cells of the natural cornea can latch on to. This process allows the implant to connect firmly while keeping the centre of the cornea free of cells, thereby not impairing the patient's vision. The optical front part of the artificial cornea is coated with a hydrophilic polymer to keep it constantly moistened with tear fluid.

The first implants have already undergone successful animal testing and the researchers hope to begin human trials in 2008.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.